Well not exactly they never actually published a costing only ever estimated numbers that as you say were way under estimated - perhaps they should have paid for a BFS at the get go .
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025